Finance

Lists
UQ1:FRA
Uniqure NV
€39.30
-1.38%
(-0.55) 1D
Sep 10, 8:10:23 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for UQ1...
Open
€39.30
High
€39.30
Low
€39.30
Mkt. cap
3.12B
Avg. vol.
11.00
Volume
0.00
52-wk high
€60.50
52-wk low
€7.26
No. of employees
221
Open
€39.30
High
€39.30
Low
€39.30
Mkt. cap
3.12B
Avg. vol.
11.00
Volume
0.00
52-wk high
€60.50
52-wk low
€7.26
No. of employees
221
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV
CEOMatt Kapusta
Employees221
Founded1998
Headquarters-
SectorBiotechnology
Websiteuniqure.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.70M
5.57M
3.56M
5.84M
Cost of goods sold
32.25M
40.18M
30.73M
30.66M
Cost of revenue
32.25M
40.18M
30.73M
30.66M
Research and development expenses
695.00K
-5.92M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.44M
21.61M
20.07M
19.77M
Operating expense
20.67M
15.55M
19.89M
26.13M
Total operating expenses
52.91M
55.73M
50.62M
56.79M
Operating income
-49.21M
-50.16M
-47.06M
-50.95M
Other non operating income
-7.22M
18.13M
3.77M
-15.97M
EBT including unusual items
-71.90M
-41.00M
-53.05M
-79.22M
EBT excluding unusual items
-70.08M
-40.05M
-54.38M
-77.96M
Income tax expense
8.63M
-3.92M
488.00K
1.84M
Effective tax rate
-12.00%
9.55%
-0.92%
-2.32%
Other operating expenses
534.00K
-143.00K
-181.00K
6.36M
Net income
-80.53M
-37.09M
-53.54M
-81.06M
Net profit margin
-2,175.87%
-666.06%
-1,502.95%
-1,387.76%
Earnings per share
-
-
-
-
Interest and investment income
3.50M
5.81M
5.23M
5.05M
Interest expense
-16.72M
-14.57M
-14.03M
-14.37M
Net interest expenses
-13.22M
-8.76M
-8.80M
-9.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.58M
-47.19M
-44.10M
-46.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps